Lifestyle Intervention Can Prevent Weight Gain during Menopause: Results from a 5-Year Randomized Clinical Trial

Annals of Behavioral Medicine

Volumn 26, Issue 3, 2003, Pages 212-220

  Simkin Silverman, Laurey R ^a   Wing, Rena R ^a,b   Boraz, Miriam A ^a   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; MENOPAUSE; PHYSICAL ACTIVITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0347985002     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15324796ABM2603_06     Document Type: Article

References (26)

1. Pi-Sunyer FX: Medical hazards of obesity. Annals of Internal Medicine. 1993, 119:655-660.
2. National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, NIH Publication No. 98-4083. Bethesda, MD: 1998.
3. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: Prevalence and trends, 1960-1994. International Journal of Obesity. 1998, 22:39-47.
4. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL: Weight gain at the time of menopause. Archives of Internal Medicine. 1991, 151:97-102.
5. Simkin-Silverman LR, Wing RR: Weight gain during menopause: Is it inevitable or can it be prevented? Postgraduate Medicine 2000, 108:47-56.
6. Heymsfield SB, Gallagher D, Poehlman ET, et al.: Menopausal changes in body composition and energy expenditure. Experimental Gerontology. 1994, 29:377-389.
7. Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: A controlled longitudinal study. Annals of Internal Medicine. 1995, 123:673-675.
8. Jeffery RW, French SA: Preventing weight gain in adults: The pound of prevention study. American Journal of Public Health. 1999, 89:747-751.
9. Boraz MA, Simkin-Silverman LR, Wing RR, Meilhan EN, Kuller LH: HRT use and menopausal symptoms among women participating in a behavioral lifestyle intervention. Preventive Medicine. 2001, 33:108-114.
10. Salamone LM, Cauley JA, Black DM, et al.: Effect of a lifestyle intervention on bone mineral density in premenopausal women: A randomized trial. American Journal of Clinical Nutrition. 1999, 70:97-103.
11. Simkin-Silverman L, Wing RR, Hansen DH, et al: Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Preventive Medicine. 1995, 24:509-517.
12. Simkin-Silverman LR, Wing RR, Boraz MA, Meilahn EN, Kuller LH: Maintenance of cardiovascular risk factor changes among middle-aged women in a lifestyle intervention trial. Women's Health: Research on Gender, Behavior, and Policy. 1998, 4:255-271.
13. Kuller LH, Simkin-Silverman LR, Wing RR, Meilahn EN, Ives DG: Women's healthy lifestyle project: A randomized clinical trial: Results at 54 months. Circulation. 2001, 103:32-37.
14. Wing RR: Behavioral approaches to the treatment of obesity. In Bray G, Bouchard C, James PT (eds), Handbook of Obesity. New York: Dekker, 1998, 855-871.
15. Lohman TG, Roche AF, Martorell R: Anthropometric Standardization Reference Manual. Campaign, IL: Human Kinetics, 1988.
16. Paffenbarger RS, Wing AL, Hyde RT: Physical activity as an index of heart attack risk in college alumni. American Journal of Epidemiology. 1978, 108:161-175.
17. Block G, Hartman AM, Dresser CM, et al.: A data-based approach to diet questionnaire design and testing. American Journal of Epidemiology. 1986, 124:453-469.
18. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clinical Chemistry. 1974, 20:470-475.
19. Bonder RJL, Mead DC: Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clinical Chemistry. 1974, 20:586.
20. Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clinical Chemistry. 1973, 19:476-482.
21. Wamick GR, Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. Journal of Lipid Research. 1978, 19:65-76.
22. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clinical Chemistry. 1972, 18:499-502.
23. Dischinger P, DuChene AG: Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Controlled Clinical Trials. 1986, 7(Suppl.):137S-157S.
24. Garrow JS: Zero-muddler for unprejudiced sphygmomanometry. Lancet. 1963, 2:1205.
25. Klem ML, Wing RR, Simkin-Silverman L, Kuller LH: The psychological consequences of weight gain prevention in healthy, premenopausal women. International Journal of Eating Disorders. 1997, 21:167-174.
26. Dunn AL, Marcus BH, Kampert JB, et al.: Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: A randomized trial. Journal of the American Medical Association. 1999, 281:327-334.